Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression

• Objective: Transforming growth factor-β (TGF-β) plays an important role in wound healing. Delayed wound healing is a consequence of diabetes, leading to high morbidity and poor quality of life. Momordica charantia (MC) fruit possesses anti-diabetic and wound healing properties. This study aimed to...

Full description

Bibliographic Details
Published in:Journal of Wound Care
Main Author: Hussan F.; Teoh S.L.; Muhamad N.; Mazlan M.; Latiff A.A.
Format: Article
Language:English
Published: MA Healthcare Ltd 2014
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907868220&doi=10.12968%2fjowc.2014.23.8.400&partnerID=40&md5=818bdb15166e7db654a0307306fe6240
id 2-s2.0-84907868220
spelling 2-s2.0-84907868220
Hussan F.; Teoh S.L.; Muhamad N.; Mazlan M.; Latiff A.A.
Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression
2014
Journal of Wound Care
23
8
10.12968/jowc.2014.23.8.400
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907868220&doi=10.12968%2fjowc.2014.23.8.400&partnerID=40&md5=818bdb15166e7db654a0307306fe6240
• Objective: Transforming growth factor-β (TGF-β) plays an important role in wound healing. Delayed wound healing is a consequence of diabetes, leading to high morbidity and poor quality of life. Momordica charantia (MC) fruit possesses anti-diabetic and wound healing properties. This study aimed to explore the changes in TGF-β expression in diabetic wounds treated with topical MC fruit extract.; Methods: Fifty-six male Sprague-Dawley rats were divided into a normal control group and five diabetic groups of ten rats each. Intravenous streptozotocin (50mg/kg) was given to induce diabetes in the diabetic groups. Full thickness excision wounds were created on the thoracodorsal region of the animals, and these wounds were then treated with vehicle, MC powder, MC ointment and povidone ointment or ointment base for ten days. Wound healing was determined by the rate of wound closure, total protein content and TGF-β expression in the wounds, and histological observation.; Declaration of interest: There is no conflict of interest.; Results: Diabetic groups showed delayed wound closure rates compared to the control group. The wound closure rate in the MC ointment group was significantly faster than that of the untreated diabetic group (p<0.05). The MC ointment group also showed intense TGF-β expression and a high level of total protein content.; Conclusion: MC ointment has a promising potential for use as an alternative topical medication for diabetic wounds. This work has shown that it accelerates wound healing in diabetic rats, and it is suggested here that this occurs by enhancing TGF-β expression. Further work is recommended to explore this effect. © 2014 MA Healthcare LTD.
MA Healthcare Ltd
09690700
English
Article

author Hussan F.; Teoh S.L.; Muhamad N.; Mazlan M.; Latiff A.A.
spellingShingle Hussan F.; Teoh S.L.; Muhamad N.; Mazlan M.; Latiff A.A.
Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression
author_facet Hussan F.; Teoh S.L.; Muhamad N.; Mazlan M.; Latiff A.A.
author_sort Hussan F.; Teoh S.L.; Muhamad N.; Mazlan M.; Latiff A.A.
title Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression
title_short Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression
title_full Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression
title_fullStr Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression
title_full_unstemmed Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression
title_sort Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression
publishDate 2014
container_title Journal of Wound Care
container_volume 23
container_issue 8
doi_str_mv 10.12968/jowc.2014.23.8.400
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907868220&doi=10.12968%2fjowc.2014.23.8.400&partnerID=40&md5=818bdb15166e7db654a0307306fe6240
description • Objective: Transforming growth factor-β (TGF-β) plays an important role in wound healing. Delayed wound healing is a consequence of diabetes, leading to high morbidity and poor quality of life. Momordica charantia (MC) fruit possesses anti-diabetic and wound healing properties. This study aimed to explore the changes in TGF-β expression in diabetic wounds treated with topical MC fruit extract.; Methods: Fifty-six male Sprague-Dawley rats were divided into a normal control group and five diabetic groups of ten rats each. Intravenous streptozotocin (50mg/kg) was given to induce diabetes in the diabetic groups. Full thickness excision wounds were created on the thoracodorsal region of the animals, and these wounds were then treated with vehicle, MC powder, MC ointment and povidone ointment or ointment base for ten days. Wound healing was determined by the rate of wound closure, total protein content and TGF-β expression in the wounds, and histological observation.; Declaration of interest: There is no conflict of interest.; Results: Diabetic groups showed delayed wound closure rates compared to the control group. The wound closure rate in the MC ointment group was significantly faster than that of the untreated diabetic group (p<0.05). The MC ointment group also showed intense TGF-β expression and a high level of total protein content.; Conclusion: MC ointment has a promising potential for use as an alternative topical medication for diabetic wounds. This work has shown that it accelerates wound healing in diabetic rats, and it is suggested here that this occurs by enhancing TGF-β expression. Further work is recommended to explore this effect. © 2014 MA Healthcare LTD.
publisher MA Healthcare Ltd
issn 09690700
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1814778510305132544